Investor Relations

VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for people living with immune-inflammatory diseases.

Events & Presentations

More events are coming soon.

Press Releases

September 6, 2023
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Read More
August 14, 2023
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Read More

Corporate Presentation

More information is coming soon.
September 16, 2023 3:43 PM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart